Company News 

Hospital group directors inject much-needed confidence

Hospital group directors inject much-needed confidence

The collapse of the Mediclinic (MDC) and Spire (SPI) merger has left both companies’ share prices nursing hangovers. What better time for an injection of confidence by senior management. Spire’s new chief executive, Justin Ash – who took the top job in early October – spent £199,843 on 84,000 new shares, while Mediclinic’s chief financial officer doubled his holding on the Johannesburg Stock Exchange.

To continue reading, subscribe today

and enjoy unlimited access to the following:

  • Tips of the Week
  • Funds coverage
  • Weekly features on big investment themes
  • Trading ideas
  • Comprehensive companies coverage
  • Economic analysis
Subscribe to Investors Chronicle

Subscribe today

Full access for just £3.37 a week:

• Tips and recommendations - to beat the market 
• Portfolio clinic & Mr Bearbull - build a well-planned portfolio 
• Expert tools - track and manage investments effortlessly
• Plus free delivery to your home or office

Subscribe Now